Timing of TAP Blocks in Bariatric Surgery
Single Blind Clinical Trial: Optimizing TAP Block Timing for Bariatric Surgery
1 other identifier
interventional
100
1 country
1
Brief Summary
This clinical trial aims to determine the optimal timing for administering a Transversus Abdominis Plane (TAP) block in bariatric surgery, specifically investigating whether initiating TAP blocks at the beginning of surgery is more beneficial than at the end, which is the current practice. The study targets obese patients undergoing bariatric surgery, with a focus on reducing postoperative pain and opioid use. Key outcomes include recovery duration, pain levels, opioid consumption, and respiratory function. Successful results could establish early TAP block initiation as a standard practice, offering faster recovery, decreased opioid reliance, and reduced healthcare costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Nov 2024
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedStudy Start
First participant enrolled
November 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2025
CompletedNovember 25, 2024
November 1, 2024
2 months
February 6, 2024
November 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Opioid Consumption
Opioid Consumption in the post- anesthetic recovery unit
Immediately post-op
Secondary Outcomes (6)
Length of Stay
immediately post-operative
Anesthesia requirements
Intra-operatively
Sedation requirements
post-operative up to 24 Hours
Nausea and vomiting
post-operative up to 24 Hours
Respiratory Status
immediately post-operative
- +1 more secondary outcomes
Study Arms (2)
Early TAP block
EXPERIMENTALPatients in this group will receive TAP blocks at the beginning of the procedure
Late TAP block
ACTIVE COMPARATORPatients in this group will receive TAP blocks at the end of their procedure, which is the current standard practice.
Interventions
A total of 60ml of 0.25% Bupivacaine with Epinephrine, divided into 4 aliquots, will be administered laparoscopically at two locations per side along the anterior axillary line between the costal margin and the iliac crest. TAP block timing will be disclosed to the operating surgeon to ensure the correct solution is administered at the appropriate time.
Eligibility Criteria
You may qualify if:
- Patients undergoing primary bariatric surgery at St. Joseph's Healthcare Hamilton surgery including Sleeve Gastrectomy (SG) or Roux-en-Y Gastric Bypass Surgery (RYGB)
- Patients \>18 Years of Age
You may not qualify if:
- Patients undergoing a revisional bariatric surgery
- Patients with a history of chronic pain or opioid use.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Joseph's Healthcare Hamilton - Charlton Campus
Hamilton, Ontario, L8N 4A6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2024
First Posted
February 21, 2024
Study Start
November 21, 2024
Primary Completion
January 31, 2025
Study Completion
June 28, 2025
Last Updated
November 25, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share